Metraipolis › archive › dc_2b4e6c08131e

Metabolite profiles associated with disease progression in influenza infection — Europe PMC PMID:33798209

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33798209
DOI
10.1371/journal.pone.0247493
License (as archived)
CC0-1.0
Archived
2026-11-05T04:23:10.558Z
SHA-256 of the archived text
a218745300b8ce6bbf4fa5eb2bcbefb73c2547efb90f85ac2ead4b3c6feeb87e
Stable URL of this page
https://metraipolis.com/documento/dc_2b4e6c08131e

How to cite

Metabolite profiles associated with disease progression in influenza infection — Europe PMC PMID:33798209 — Europe PMC (en), https://europepmc.org/article/MED/33798209 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_2b4e6c08131e (Metraipolis archive dc_2b4e6c08131e, sha256 a218745300b8ce6bbf4fa5eb2bcbefb73c2547efb90f85ac2ead4b3c6feeb87e)
BibTeX
@misc{dc2b4e6c08131e,
  title = {Metabolite profiles associated with disease progression in influenza infection — Europe PMC PMID:33798209},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33798209},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_2b4e6c08131e; sha256 a218745300b8ce6bbf4fa5eb2bcbefb73c2547efb90f85ac2ead4b3c6feeb87e},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33798209. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: We performed metabolomic profiling to identify metabolites that correlate with disease progression and death. Methods: We performed a study of adults hospitalized with Influenza A(H1N1)pdm09. Cases (n = 32) were defined by a composite outcome of death or transfer to the intensive care unit during the 60-day follow-up period. Controls (n = 64) were survivors who did not require transfer to the ICU. Four hundred and eight metabolites from eight families were measured on plasma sample at enrollment using a mass spectrometry based Biocrates platform. Conditional logistic regression was used to summarize the association of the individual metabolites and families with the composite outcome and its major two components. Results: The ten metabolites with the strongest association with disease progression belonged to five different metabolite families with sphingolipids being the most common. The acylcarnitines, glycerides, sphingolipids and biogenic metabolite families had the largest odds ratios based on the composite endpoint. The tryptophan odds ratio for the composite is largely associated with death (OR 17.33: 95% CI, 1.60-187.76). Conclusions: Individuals that develop disease progression when infected with Influenza H1N1 have a metabolite signature that differs from survivors. Low levels of tryptophan had a strong association with death. Registry: ClinicalTrials.gov Identifier: NCT01056185.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-04-02).
Identificativi: PMID 33798209 · PMCID PMC8018623 · DOI 10.1371/journal.pone.0247493.
Descrittori MeSH principali: Metabolome.
Pagina: https://europepmc.org/article/MED/33798209 — https://doi.org/10.1371/journal.pone.0247493. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-05T04:17:33.985Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.